Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal

Fig. 4

Intracellular ICD marker and DCs maturation of UCMS@Pep in vitro. A CRT exposure and (B) HMGB1 analysis by immunofluorescence using CLSM (scale bar = 25 μm). Release of (C) ATP and (D) HMGB1 detected by ELISA kits for different interventions. E Schematic of the trans-well DCs maturation system. F Flow cytometry results for mature DCs after different treatments. Levels of cytokines (G) TNF-α and (H) IL-12 in the culture medium. (*P < 0.05, **P < 0.01, ***P < 0.001, n = 3)

Back to article page